Teva Pharmaceuticals International GmbH et al v. Eli Lilly and Company

  1. November 27, 2023

    Teva, Eli Lilly Call Off Infringement Suit Over Migraine Drug

    Teva Pharmaceuticals International GmbH has moved in Massachusetts federal court to permanently drop an infringement case against Eli Lilly and Co. over a migraine drug — an action taken after the Patent Trial and Appeal Board found two patents related to the drug and its use invalid.

  2. March 15, 2022

    Judge Won't Toss Teva's Migraine Drug IP Suit Against Eli Lilly

    A Massachusetts federal judge refused on Tuesday to boot Teva Pharmaceutical's patent suit against rival Eli Lilly over a competing migraine medication, ruling that Eli Lilly was relying on claim construction arguments that were inappropriate at this early stage of the case.

  3. October 19, 2021

    Teva Fights Eli Lilly's Bid To Toss Migraine Drug IP Case

    Teva Pharmaceuticals says that Eli Lilly shouldn't be able to dodge a suit alleging an Eli Lilly migraine drug infringes a pair of Teva patents, arguing that the complaint is adequately pled.

  4. June 08, 2021

    Hours After Getting Patents, Teva Sues Eli Lilly Again

    Teva Pharmaceuticals lodged a new infringement suit against rival Eli Lilly in Massachusetts federal court Tuesday mere hours after the U.S. Patent and Trademark Office issued the company two new patents covering the Israeli drugmaker's blockbuster migraine drug Ajovy.